Shots:
- The companies reported that joint Livongo for diabetes and dexcom members will now receive CGM-powered insights that enables members to easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels
- In Oct’2020, Teldoc merges with Livongo while in Jan’2020 Dexcom collaborated with Livongo to integrate Dexcom’s G6 CGM system into Livongo’s applied health signals platform
- Both the companies will launch a pilot demonstrating the impact of CGM-powered insights for people with T2D, with a broader launch across 2021
Click here to read full press release/ article | Ref: Teladoc Health | Image: Teladoc Health
The post Teladoc Health and Dexcom Offers CGM-Powered Insight for T2D first appeared on PharmaShots.
